GRIFOLS, SAGRIFOLS, SAGRIFOLS, SA

GRIFOLS, SA

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪5.53 B‬EUR
‪59.31 M‬EUR
‪6.59 B‬EUR
‪291.12 M‬
Beta (1Y)
1.23
Employees (FY)
‪23.74 K‬
Change (1Y)
‪−2.58 K‬ −9.81%
Revenue / Employee (1Y)
‪277.63 K‬EUR
Net income / Employee (1Y)
‪2.50 K‬EUR

About GRIFOLS S.A.


CEO
Nacho Abia
Headquarters
Barcelona
Founded
1940
ISIN
ES0171996087
FIGI
BBG000PL4VX6
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
XS239300189
GRIFOLS S.A. 21/28 REGS
Yield to maturity
7.25%
Maturity date
Oct 15, 2028
GRFS5271380
Grifols Escrow Issuer SA 4.75% 15-OCT-2028
Yield to maturity
7.15%
Maturity date
Oct 15, 2028
XS207683655
GRIFOLS 19/25 REGS
Yield to maturity
4.96%
Maturity date
Feb 15, 2025
XS207764639
GRIFOLS 19/27 REGS
Yield to maturity
4.62%
Maturity date
Nov 15, 2027

Explore more bonds 

Frequently Asked Questions


The current price of OZTA is 9.61 EUR — it has increased by 2.04% in the past 24 hours. Watch GRIFOLS, SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange GRIFOLS, SA stocks are traded under the ticker OZTA.
OZTA stock has risen by 6.12% compared to the previous week, the month change is a −18.77% fall, over the last year GRIFOLS, SA has showed a −31.06% decrease.
We've gathered analysts' opinions on GRIFOLS, SA future price: according to them, OZTA price has a max estimate of 27.00 EUR and a min estimate of 9.00 EUR. Watch OZTA chart and read a more detailed GRIFOLS, SA stock forecast: see what analysts think of GRIFOLS, SA and suggest that you do with its stocks.
OZTA reached its all-time high on Feb 21, 2020 with the price of 34.20 EUR, and its all-time low was 6.37 EUR and was reached on Mar 6, 2024. View more price dynamics on OZTA chart.
See other stocks reaching their highest and lowest prices.
OZTA stock is 8.76% volatile and has beta coefficient of 1.23. Track GRIFOLS, SA stock price on the chart and check out the list of the most volatile stocks — is GRIFOLS, SA there?
Today GRIFOLS, SA has the market capitalization of ‪6.00 B‬, it has increased by 0.57% over the last week.
Yes, you can track GRIFOLS, SA financials in yearly and quarterly reports right on TradingView.
GRIFOLS, SA is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
OZTA earnings for the last quarter are 0.23 EUR per share, whereas the estimation was 0.20 EUR resulting in a 14.90% surprise. The estimated earnings for the next quarter are 0.22 EUR per share. See more details about GRIFOLS, SA earnings.
GRIFOLS, SA revenue for the last quarter amounts to ‪1.79 B‬ EUR, despite the estimated figure of ‪1.76 B‬ EUR. In the next quarter, revenue is expected to reach ‪1.87 B‬ EUR.
OZTA net income for the last quarter is ‪51.69 M‬ EUR, while the quarter before that showed ‪14.84 M‬ EUR of net income which accounts for 248.30% change. Track more GRIFOLS, SA financial stats to get the full picture.
GRIFOLS, SA dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 12, 2024, the company has ‪23.74 K‬ employees. See our rating of the largest employees — is GRIFOLS, SA on this list?
Like other stocks, OZTA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GRIFOLS, SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GRIFOLS, SA technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GRIFOLS, SA stock shows the sell signal. See more of GRIFOLS, SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.